SHC1 sensitizes cancer cells to the 8-Cl-cAMP treatment

Ki Young Choi, Young Jun Cho, Jeong Seon Kim, Young Ho Ahn, Seung Hwan Hong

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

8-Chloro-cyclic AMP (8-Cl-cAMP) is a cyclic AMP analog that induces growth inhibition and apoptosis in a broad spectrum of cancer cells. Previously, we found that 8-Cl-cAMP-induced growth inhibition is mediated by AMP-activated protein kinase (AMPK) as well as p38 mitogen-activated protein kinase (p38 MAPK). To identify downstream mediators of the 8-Cl-cAMP signaling, we performed co-immunoprecipitation combined with mass spectrometry using the anti-AMPK or p38 MAPK antibodies. Through this approach, SHC1 was identified as one of the binding partners of p38 MAPK. SHC1 phosphorylation was suppressed by 8-Cl-cAMP in HeLa and MCF7 cancer cells, which was mediated by its metabolites, 8-Cl-adenosine and 8-Cl-ATP; however, 8-Cl-cAMP showed no effect on SHC1 phosphorylation in normal human fibroblasts. SHC1 siRNA induced AMPK and p38 MAPK phosphorylation and growth inhibition in cancer cells, and SHC1 overexpression re-sensitized human foreskin fibroblasts to the 8-Cl-cAMP treatment. SHC1 phosphorylation was unaffected by Compound C (an AMPK inhibitor) and SB203580 (a p38 MAPK inhibitor), which suggests that SHC1 is upstream of AMPK and p38 MAPK in the 8-Cl-cAMP-stimulated signaling cascade. On the basis of these findings, we conclude that SHC1 functions as a sensor during the 8-Cl-cAMP-induced growth inhibition in SHC1-overexpressing cancer cells.

Original languageEnglish
Pages (from-to)673-678
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume463
Issue number4
DOIs
StatePublished - 13 Jul 2015

Keywords

  • 8-Chloro-cyclic AMP
  • AMP-activated protein kinase
  • Cancer therapy
  • SHC1
  • p38 MAP kinase

Fingerprint

Dive into the research topics of 'SHC1 sensitizes cancer cells to the 8-Cl-cAMP treatment'. Together they form a unique fingerprint.

Cite this